References

• Bornemann, J., Close, J. B., Ahmad, K., Barba, T., Godfrey, K., Macdonald, L., Erritzoe, D., Nutt, D., & Carhart-Harris, R. (2024). Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action.” Frontiers in Psychiatry, 15, 1320780. https://doi.org/10.3389/fpsyt.2024.1320780
• Carhart-Harris, R.L., et al. (2024). Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study (Protocol). Frontiers in Psychiatry, 12, Article 735523. https://doi.org/10.3389/fpsyt.2021.735523 ICHGCP+8The Australian+8ScienceBlog.com+8Frontiers+4ICHGCP+4Carhart-HarrisLab+4Frontiers+6Frontiers+6SpringerLink+6
• Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021). Trial of Psilocybin versus Escitalopram for Depression. The New England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/NEJMoa2032994